• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/16

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

16 Cards in this Set

  • Front
  • Back

plasmapherisis is a possible treatment for!

waldenstrom macroglobulinemia

patients with waldenstrom macroglobulinemia frequently encounter thrombotic complication because of!

coating of platelets and clotting by increased IgM.

All of the following are consistant with the clinical and pathologic picture of waldenstrom macroglobinemia except!

destructive bone lesions.

A significant feature of hairy cell leukemia not seen in other acute leukemias is:

Rouleaux.

Which of the following is the predominant res blood cell morphology in patients with MDS?

Macrocytes.

What is the cutoff blast count used to distinguish a patient with MDS from a patient with acute leukemia?

20%

What is the cutoff blast count used to distinguish a patient with MDS from a patient with acute leukemia?

20%

The most common hematologic malignancy in adult is:

Myelodysplastic syndrome.

What is the cutoff blast count used to distinguish a patient with MDS from a patient with acute leukemia?

20%

The most common hematologic malignancy in adult is:

Myelodysplastic syndrome.

All of the following are features of MDS except:

Organomegaly

What is the cutoff blast count used to distinguish a patient with MDS from a patient with acute leukemia?

20%

The most common hematologic malignancy in adult is:

Myelodysplastic syndrome.

All of the following are features of MDS except:

Organomegaly

The morphologic classification of anemia in MDS is:

Macrocytic, normochromic

The most effective means of treating iron overload in MDS is:

Iron chelation therapy